Recombinant Acellular Pertussis Vaccine

pertussis vaccine, recombinant acellular · BioNet-Asia Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant Acellular Pertussis Vaccine, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults [Phase 3]